Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

Research output: Contribution to journalJournal articlepeer-review

  • Anders Granholm
  • Marie Warrer Munch
  • Sheila Nainan Myatra
  • Bharath Kumar Tirupakuzhi Vijayaraghavan
  • Maria Cronhjort
  • Rebecka Rubenson Wahlin
  • Stephan M. Jakob
  • Luca Cioccari
  • Maj-Brit Norregaard Kjaer
  • Gitte Kingo Vesterlund
  • Tine Sylvest Meyhoff
  • Marie Helleberg
  • Balasubramanian Venkatesh
  • Naomi E. Hammond
  • Sharon Micallef
  • Abhinav Bassi
  • Oommen John
  • Vivekanand Jha
  • Vibeke Lind Jorgensen
  • Margit Smitt
  • Lone Musaeus Poulsen
  • Bodil Steen Rasmussen
  • Anne Craveiro Brochner
  • Thomas Strom
  • Anders Moller
  • Mohd Saif Khan
  • Ajay Padmanaban
  • Jigeeshu Vasishtha Divatia
  • Sanjith Saseedharan
  • Kapil Borawake
  • Farhad Kapadia
  • Subhal Dixit
  • Rajesh Chawla
  • Urvi Shukla
  • Pravin Amin
  • Michelle S. Chew
  • Christian Aage Wamberg
  • Christian Gluud
Original languageEnglish
JournalIntensive Care Medicine
Volume48
Pages (from-to)45–55
Number of pages11
ISSN0342-4642
DOIs
Publication statusPublished - 2022

    Research areas

  • COVID-19, Hypoxaemia, Critical illness, Corticosteroids, Bayesian analysis

ID: 285184313